Lastest News


4 types of pet vaccines and Heartgard excluded from range of veterinary prescription drugs

The ‘Range of Pharmaceutical Products Prescribed as Veterinary Drug,’ which may have caused high medical expenses for animal treatment by restricting treatment options in the circumstance where pet insurance is not ap...

228 new drug approvals after 2010, 13 of them developed by Korea

There have been 228 products approved as new drug in Korea since 2010, and 13 of them were developed by Korean pharmaceutical companies. According to the Ministry of Food and Drug Safety, the number of new drugs appr...

Rapid decrease in products bioequivalently approved

There were 227 pharmaceutical products newly approved in bioequivalence test this year, decreased by more than 40% compared to the same period of the last year. On the 22nd of May, the Ministry of Food and Drug Safet...

HIRA reveals 84 medical institutes well treating breast cancer

Which medical institutes are good at treating breast cancer that is common for women in the 40s? According the result of the 1st to 4th propriety studies for breast cancer, the total 84 institutes received Grade 1. T...

Ildong’s ‘Besivo’ shows equivalence and improved safety to Viread

“Besivo, a chronic hepatitis B treatment, is a product which proved equivalent efficacy and improved safety to Viread.” Ildong Pharmaceutical held a press conference for ‘Besivo Tab,’ a new chronic hepatitis B treatm...

Approvals for OTC medicines keep dropping

It was analyzed the number of approvals(registrations) for OTC medicine has continuously decreased since 2014. According to the Ministry of Food and Drug Safety, the number of ETC medicines approved(registered) last ...

Il-Yang Pharmaceutical, “Wonbi-D exceeded KRW 30 billion sales in China last year”

Il-Yang Pharmaceutical’s ‘Wonbi-D’ continues its rapid growth as recording more than KRW 30 sales in China. According to the company, the ‘Wonbi-D’ sales have been increased ev...

SamjinPharm’s ‘Research for Targeted Therapy for Metastatic Breast Cancer’ selected for government’s support

SamjinPharm(CEO Sung-Woo Lee) Central Laboratory announced its ‘Development Project of Targeted Therapy for Metastatic Breast Cancer Patients’ was selected as part of the ‘New D...

Samil Pharmaceutical signs MOU to develop innovative products with Yozma Group Korea

Samil Pharmaceutical(CEO Seung-Bum Huh) signed a memorandum of understanding for strategic partnership and commercialization of innovative new products related to medicine, heal...

Gems Korea supplies entire products of Mölnlycke Health Care across the nation

Gems Korea(CEO Young-Suh Park) has started to supply the entire products of Mölnlycke Health Care(CEO Seung-Woon Kim), a leading pharmaceutical company in the scar treatment field, to hospitals across the nation since...

9 of 24 new drugs approved last year was antibiotic neoplastic agent

It was observed there were 24 pharmaceutical products approved as new drug in Korea, and 9 of them were anticancer drugs. In the recently-published ‘2016 Drug Approval Report,’ the Ministry of Food and Drug Safety an...

Janssen files patent infringement trial against Samsung Bioepis

Janssen, a U.S. global pharmaceutical company, filed a patent infringement trial against Samsung Bioepis. Janssen recently sued Samsung Bioepis for infringing the 3 patents of ...

MFDS designates products similar to teeth whitening as quasi drug

Products that are similar to teeth whitening kits will be controlled by being designated by the government as quasi drug. The Ministry of Food and Drug Safety(MFDS) made a partial revision to the ‘Notification of the...

“The government must control illegal sales of OTC medicines at supermarkets and local stores”

The Korean Pharmaceutical Association(Chairman Chan-Hwi Cho, KPA) released an written statement to take term measures against illegal sales of pharmaceutical products at supermarkets and local stores. A number of sup...

GreenCross MS supplies hemodialysis solutions of KRW 90 billion to Boryung Pharm

GreenCross Medical Science(CEO Young-Pil Kim, GreenCross MS) announced on the 19th it signed a long-term supply agreement of supplying hemodialysis solutions for 10 years with Boryung Pharm(CEO Tae-Hong Choi). GreenC...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.